BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$3.89 -0.05 (-1.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Investment Gain (Loss) (2024 - 2025)

Updated

BridgeBio Oncology Therapeutics (BBOT) reported Investment Gain (Loss) of $1,159 for Q2 2025, down 52.6% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Investment Gain (Loss) (2024 - 2025) Analysis & Trends

Over the twelve months ended Jun 30, 2025, BridgeBio Oncology Therapeutics' Investment Gain (Loss) came in at $9,786; for FY2024, it came in at $6,182.

  • Per Business Quant data, the three quarters before Q2 2025 came in at $2,445 (Q1 2025), $3,182 (Q4 2024) and $3,000 (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investment Gain (Loss) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 BridgeBio Oncology Therapeutics 311.65 Mn -1.06 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1,159.00
Mar 31, 2025 2,445.00
Dec 31, 2024 3,182.00
Sep 30, 2024 3,000.00
API Access

BridgeBio Oncology Therapeutics Investment Gain (Loss) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=investment-gain-loss&ticker=BBOT&period=max&api_key=YOUR_API_KEY